• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session

    7/26/22 1:13:24 PM ET
    $AAMC
    $AAN
    $AYLA
    $BBIG
    Real Estate
    Finance
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $AAMC alert in real time by email

    Gainers

    • Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) gained 59.2% to $1.6400.
    • Freight Technologies, Inc. (NASDAQ:FRGT) rose 52% to $2.25 after the company announced it was awarded Samsung Mexico SDS business and has begun using its platform to assist with effecting Samsung's shipments from Mexico to the United States.
    • InflaRx N.V. (NASDAQ:IFRX) jumped 45.4% to $2.0200 after the company announced plans to apply for Emergency Use Authorization from the FDA for vilobelimab for the treatment of critically ill COVID-19 patients.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) rose 33.4% to $2.1207. GeoVax Labs shares jumped 150% on Monday on news that WHO has declared Monkeypox a public health emergency over the weekend.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) gained 30.7% to $12.52. The stock has seen continued volatility after the company completed its SPAC merger agreement last month.
    • Nutriband Inc. (NASDAQ:NTRB) gained 27.6% to $6.49. Nutriband said 1.2 million shares will be cancelled from total outstanding shares following final court judgment in favor of the company.
    • Chimerix, Inc. (NASDAQ:CMRX) rose 25% to $2.5494.
    • Versus Systems Inc. (NASDAQ:VS) gained 19.6% to $0.54 after the USPTO issued U.S. Patent No. 11,376,498 to the company to cover games and challenges that produce real world rewards inside of apps and streaming media.
    • Evaxion Biotech A/S (NASDAQ:EVAX) gained 18.3% to $3.0050. Oppenheimer recently assumed Evaxion Biotech with an Outperform rating and announced a price target of $16.
    • Code Chain New Continent Limited (NASDAQ:CCNC) rose 16.4% to $0.3570 after dropping over 19% on Monday.
    • Covenant Logistics Group, Inc. (NASDAQ:CVLG) climbed 15.8% to $33.84 following better-than-expected Q2 results.
    • Calix Inc (NYSE:CALX) shares gained 13.5% to $50.29 after the company announced upbeat Q2 results and issued strong Q3 sales forecast.
    • Altisource Asset Management Corporation (NYSE:AAMC) rose 13.3% to $17.56. Altisource Asset Management recently announced it purchased 286,873 shares of its common stock from Putnam Focused Equity Fund at $10 per share
    • Encore Wire Corporation (NASDAQ:WIRE) shares gained 12.7% to $124.85 after the company reported Q2 results.
    • Empire Petroleum Corporation (NYSE:EP) rose 12.4% to $10.19.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) jumped 12% to $2.14.
    • Shell Midstream Partners, L.P. (NYSE:SHLX) rose 10.2% to $16.03 after the company, and Shell USA, announced the two have reached a definitive merger agreement.
    • TrueBlue, Inc. (NYSE:TBI) gained 9.9% to $21.06 following upbeat Q2 earnings.
    • TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) rose 9.1% to $0.8499 after gaining around 17% on Monday.
    • STRATA Skin Sciences, Inc. (NASDAQ:SSKN) rose 4.6% to $1.1502 after the company announced U.S. commercial launch of TheraClearX Acne Therapy System.


    Losers

    • Revelation Biosciences, Inc. (NASDAQ:REVB) shares fell 52.5% to $0.48 after the company reported pricing of $5 million public offering. Revelation Biosciences shares jumped 55% on Monday after the company announced the data from its Phase 1b CLEAR clinical study of REVTx-99b met the primary endpoint.
    • Luokung Technology Corp. (NASDAQ:LKCO) fell 42.4% to $0.2298 after the company announced an $8 million registered direct offering priced at $0.30 per share.
    • Exela Technologies, Inc. (NASDAQ:XELA) shares dipped 39.2% to $21.06 amid effectiveness of a 1-for-20 reverse stock split of the company's common stock.
    • Koss Corporation (NASDAQ:KOSS) fell 26.7% to $8.21. Koss shares jumped 45% on Monday following a Bloomberg Law report titled "Apple, Koss Reach Deal in AirPods Patent Case on Eve of Trial."
    • SpringBig Holdings, Inc. (NASDAQ:SBIG) dropped 18.8% to $1.6813.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) dipped 18.2% to $1.98.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 17.5% to $0.8225. Vinco Ventures postponed stockholder meeting from July 26, 2022 to August 23, 2022.
    • Verb Technology Company, Inc. (NASDAQ:VERB) dropped 16.6% to $0.7009.
    • Sundial Growers Inc. (NASDAQ:SNDL) fell 15% to $2.53 following effect of 1:10 reverse stock split.
    • Shopify Inc. (NYSE:SHOP) dropped 14.6% to $31.33 after the company announced it will lay off 10% of its workforce.
    • MINISO Group Holding Limited (NYSE:MNSO) fell 14% to $6.20. Blue Orca Capital issued a short report on MINISO Group.
    • Trinseo PLC (NYSE:TSE) fell 13.8% to $37.00 after the company announced it will pause the sale process of its styrenics business.
    • Coinbase Global, Inc. (NASDAQ:COIN) fell 13.8% to $57.82.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) dipped 13.8% to $1.1199. Kaival Brands recently announced the launch of PMI's self-contained e-vapor product, VEEBA, in Canada.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) declined 13.3% to $1.2050.
    • Histogen Inc. (NASDAQ:HSTO) fell 11.8% to $2.7599.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) declined 11% to $0.25.
    • Rent-A-Center, Inc. (NASDAQ:RCII) dipped 10.8% to $20.97.
    • The Aaron's Company, Inc. (NYSE:AAN) fell 10.8% to $13.83 after the company lowered its sales guidance for the full year.
    • Studio City International Holdings Limited (NYSE:MSC) declined 10.8% to $1.9350.
    • Cooper-Standard Holdings Inc. (NYSE:CPS) dropped 10.2% to $4.45.
    • Walmart Inc. (NYSE:WMT) shares fell 8.7% to $120.52 after the company cut guidance for the second quarter and full fiscal year. Walmart said it revised its outlook as a result of pricing actions aimed to improve inventory levels at Walmart and Sam's Club in the U.S. and mix of sales.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) shares fell 8.4% to $28.20 after gaining 9% on Monday.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) fell 7.3% to $15.57 after the company announced it has launched distribution of Monkeypox and Varicella-Zoster Viruses Real Time PCR Detection Kits in response to the world's major Monkeypox outbreak.
    Get the next $AAMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAMC
    $AAN
    $AYLA
    $BBIG

    CompanyDatePrice TargetRatingAnalyst
    Shopify Inc.
    $SHOP
    3/12/2026$165.00Overweight
    Piper Sandler
    Walmart Inc.
    $WMT
    3/5/2026Buy → Hold
    Erste Group
    Walmart Inc.
    $WMT
    2/27/2026$150.00Buy
    BofA Securities
    Walmart Inc.
    $WMT
    2/20/2026$131.00Buy → Hold
    HSBC Securities
    Walmart Inc.
    $WMT
    2/20/2026$135.00 → $140.00Outperform
    Telsey Advisory Group
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Evaxion A/S
    $EVAX
    2/19/2026$10.00Buy
    Maxim Group
    Shopify Inc.
    $SHOP
    2/17/2026$150.00Hold → Buy
    Truist
    More analyst ratings

    $AAMC
    $AAN
    $AYLA
    $BBIG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler resumed coverage on Shopify with a new price target

    Piper Sandler resumed coverage of Shopify with a rating of Overweight and set a new price target of $165.00

    3/12/26 8:55:08 AM ET
    $SHOP
    Computer Software: Prepackaged Software
    Technology

    Walmart downgraded by Erste Group

    Erste Group downgraded Walmart from Buy to Hold

    3/5/26 8:29:01 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    BofA Securities resumed coverage on Walmart with a new price target

    BofA Securities resumed coverage of Walmart with a rating of Buy and set a new price target of $150.00

    2/27/26 8:32:12 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AAMC
    $AAN
    $AYLA
    $BBIG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mastrocola David John bought $208,144 worth of shares (6,885 units at $30.23) (SEC Form 4)

    4 - Cooper-Standard Holdings Inc. (0001320461) (Issuer)

    3/13/26 5:05:43 PM ET
    $CPS
    Auto Parts:O.E.M.
    Consumer Discretionary

    CEO and President Owen Taryn R bought $77,316 worth of shares (20,400 units at $3.79), increasing direct ownership by 3% to 791,807 units (SEC Form 4)

    4 - TrueBlue, Inc. (0000768899) (Issuer)

    2/26/26 4:54:32 PM ET
    $TBI
    Professional Services
    Consumer Discretionary

    EVP, Chief Legal Officer Ferencz Garrett bought $25,270 worth of shares (7,000 units at $3.61), increasing direct ownership by 3% to 234,135 units (SEC Form 4)

    4 - TrueBlue, Inc. (0000768899) (Issuer)

    2/26/26 2:05:23 PM ET
    $TBI
    Professional Services
    Consumer Discretionary

    $AAMC
    $AAN
    $AYLA
    $BBIG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Notice to convene Evaxion's Annual General Meeting

    COPENHAGEN, Denmark, March 19, 2026 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, announces that its Annual General Meeting is convened to be held on April 16, 2026, at 14.00 CET. The meeting will be held at the company's offices, Dr Neergaards Vej 5F, 2970 Hørsholm, Denmark. The agenda and proposals can be found on Evaxion's website, along with other materials: www.evaxion.ai/investors/events-presentations/annual-general-meeting-2026/ Contact information Evaxion A/SMads KronborgVice President, Investor Relations & Communication+45 53 54 82 96 [email protected] About Evaxion Evaxion is a pione

    3/19/26 9:00:00 AM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TrueBlue Named One of the 2026 World's Most Ethical Companies®, Reinforcing Commitment to Ethical Leadership and Strong Governance

    Recognition by Ethisphere highlights TrueBlue's focus on strong governance, ethical business practices, and workforce impact TrueBlue (NYSE:TBI), a leading provider of specialized workforce solutions, today announced it has been recognized as one of the World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. "At TrueBlue, our mission to connect people and work is grounded in trust – and trust is earned through integrity, accountability, and transparency," said Taryn Owen, President and CEO of TrueBlue. "As we continue executing our strategy, these principles guide how we operate, make decisions, and serve our

    3/19/26 8:00:00 AM ET
    $TBI
    Professional Services
    Consumer Discretionary

    InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones

    Promising Phase 2a data announced for izicopan, underscoring its potential as a meaningfully differentiated, effective and safe oral inhibitor of C5aRSubstantial progress made toward Phase 2b readiness for izicopan in hidradenitis suppurativa (HS)InflaRx actively reviewing and considering additional development in ANCA‑associated vasculitis (AAV)To broaden izicopan signal-finding activities and expedite proof-of-concept studies into additional indications in inflammation and immunology (I&I), InflaRx intends to conduct a pharmacokinetic (PK) bridging study in China this yearActive dialog with potential collaborators to expedite the Company's total pipeline development goals continuesInflaRx

    3/19/26 7:30:00 AM ET
    $IFRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $AAN
    $AYLA
    $BBIG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Evaxion A/S

    3 - Evaxion A/S (0001828253) (Reporting)

    3/18/26 9:13:18 PM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Evaxion A/S

    3 - Evaxion A/S (0001828253) (Reporting)

    3/18/26 9:12:04 PM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Evaxion A/S

    3 - Evaxion A/S (0001828253) (Reporting)

    3/18/26 9:11:27 PM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAMC
    $AAN
    $AYLA
    $BBIG
    SEC Filings

    View All

    SEC Form 6-K filed by Evaxion A/S

    6-K - Evaxion A/S (0001828253) (Filer)

    3/19/26 9:10:04 AM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 6-K filed by Evaxion A/S

    6-K - Evaxion A/S (0001828253) (Filer)

    3/19/26 9:00:05 AM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 6-K filed by MINISO Group Holding Limited

    6-K - MINISO Group Holding Ltd (0001815846) (Filer)

    3/19/26 8:30:43 AM ET
    $MNSO
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AAMC
    $AAN
    $AYLA
    $BBIG
    Leadership Updates

    Live Leadership Updates

    View All

    Walmart Names Erin Nealy Cox as Chief Legal Officer

    Cox to lead Global Governance team and assume role as Corporate Secretary Walmart Inc. (NASDAQ:WMT) announced today that Erin Nealy Cox has been named Walmart's next Executive Vice President of Global Governance, Chief Legal Officer (CLO), and Corporate Secretary. Cox will assume responsibilities on April 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312066547/en/Erin Nealy Cox, Walmart's next Executive Vice President of Global Governance, Chief Legal Officer (CLO), and Corporate Secretary. "To lead Global Governance for a company of our scale and complexity, you need a leader who has thrived in the most demandin

    3/12/26 4:00:00 PM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    TOMI Environmental Solutions Appoints Total Clean Air as Preferred European Partner for SteraMist iHP Decontamination Technology

    FREDERICK, Md., March 03, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ:TOMZ), a global leader in disinfection and decontamination solutions, and Total Clean Air ("TCA"), a leading United Kingdom cleanroom design, build, and validation specialist, today announced a strategic partnership agreement establishing TCA as TOMI's Preferred European Partner for its industry-leading SteraMist iHP decontamination technology. Under this new agreement, TCA becomes the primary partner for sales, service, and technical support across the United Kingdom and the European Union. This collaboration creates a streamlined infrastructure to meet surging demand for aseptic proce

    3/3/26 8:30:00 AM ET
    $TOMZ
    Major Chemicals
    Industrials

    TrueBlue Appoints Mike Kruszewski to President of PeopleReady On-Demand

    TrueBlue (NYSE:TBI), a leading provider of specialized workforce solutions, today announced that Mike Kruszewski has been appointed President of PeopleReady On-Demand. In his expanded role, Mr. Kruszewski will lead the PeopleReady On-Demand business, with responsibility for strategy, sales, and operational performance. Mr. Kruszewski joined PeopleReady in November of 2025 as Head of Sales and has played a key role in advancing the Company's territory-based operating model, strengthening commercial execution, and expanding sales capacity in priority markets. "Since joining, Mike has sharpened our sales strategy, clarified success metrics, and aligned our teams to execute within our territo

    2/26/26 8:00:00 AM ET
    $TBI
    Professional Services
    Consumer Discretionary

    $AAMC
    $AAN
    $AYLA
    $BBIG
    Financials

    Live finance-specific insights

    View All

    InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones

    Promising Phase 2a data announced for izicopan, underscoring its potential as a meaningfully differentiated, effective and safe oral inhibitor of C5aRSubstantial progress made toward Phase 2b readiness for izicopan in hidradenitis suppurativa (HS)InflaRx actively reviewing and considering additional development in ANCA‑associated vasculitis (AAV)To broaden izicopan signal-finding activities and expedite proof-of-concept studies into additional indications in inflammation and immunology (I&I), InflaRx intends to conduct a pharmacokinetic (PK) bridging study in China this yearActive dialog with potential collaborators to expedite the Company's total pipeline development goals continuesInflaRx

    3/19/26 7:30:00 AM ET
    $IFRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Empire Petroleum Reports Financial Results for Fourth Quarter and Full Year 2025 and Provides Operational Updates

    Empire Petroleum Corporation (NYSE:EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, today announced an operational update and financial results for fourth quarter and full year 2025, including year-end 2025 proved reserves. FOURTH QUARTER AND FULL YEAR 2025 HIGHLIGHTS Produced full year 2025 net production volumes of 2,242 barrels of oil equivalent per day ("Boe/d") including 1,437 barrels of oil per day ("Bbl/d"); Boe/d is comprised of 64% oil, 18% natural gas liquids ("NGLs"), and 18% natural gas; During Q4-2025, Empire initiated a program to re-activate and work over what was or

    3/16/26 7:00:00 AM ET
    $EP
    Oil & Gas Production
    Energy

    Trinseo Reports Fourth Quarter and Full-Year 2025 Financial Results

    Fourth Quarter 2025 Highlights Cash provided by operations of $23 million and capital expenditures of $16 million resulted in Free Cash Flow* of $7 million and ending cash of $149 million (of which $2 million was restricted) and total liquidity of $334 million Net loss of $251 million and EPS of $(6.98) included pre-tax restructuring and other charges of $127 million related mainly to the previously announced closures the virgin MMA production and ACH operations at our facilities in Italy and the polystyrene assets in Germany Adjusted EBITDA* of $26 million included $6 million of unfavorable net timing and negative equity income from Americas Styrenics due to lower margins, partial

    3/13/26 11:05:00 AM ET
    $TSE
    Major Chemicals
    Industrials

    $AAMC
    $AAN
    $AYLA
    $BBIG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Trinseo PLC

    SC 13G - Trinseo PLC (0001519061) (Subject)

    12/17/24 5:11:10 PM ET
    $TSE
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Exela Technologies Inc.

    SC 13D/A - Exela Technologies, Inc. (0001620179) (Subject)

    12/3/24 4:01:40 PM ET
    $XELA
    Business Services
    Consumer Discretionary